Evidence map›Paper›PMID 27905430›Full record

ArticleNature2016

Safikhani et al. reply.

Zhaleh Safikhani, Nehme El-Hachem, Petr Smirnov, Mark Freeman, Anna Goldenberg, Nicolai J Birkbak, Andrew H Beck, Hugo J W L Aerts, John Quackenbush, Benjamin Haibe-Kains

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Patient-Derived In Vitro and In Vivo Models of Cancer.Advances in experimental medicine and biology · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhaleh SafikhaniPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
Nehme El-HachemInstitut de recherches cliniques de Montréal, Montreal, Quebec H2W 1R7, Canada.
Petr SmirnovPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
Mark FreemanPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
Anna GoldenbergHospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Nicolai J BirkbakThe Francis Crick Institute, University College London, London NW1 1AT, UK.University College London Cancer Institute, London, WC1E 6BT, UK.
Andrew H BeckBeth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Hugo J W L AertsHarvard Medical School, Boston, Massachusetts 02115, USA.
John QuackenbushDana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27905430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.